Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer

SOUTH SAN FRANCISCO, Calif., January 03, 2024--Switch Therapeutics today announced the appointment of Charles Allerson, Ph.D., as Chief Technology Officer (CTO).

Related Keywords

South San Francisco ,California ,United States ,South Korea ,Han ,Dtx Pharma ,Tressa Frankel ,Dee Datta ,Charles Allerson ,National Institutes Of Health ,Harvard University ,Linkedin ,Lafayette College ,Harvard Medical School ,Ionis Pharmaceuticals ,Novartis ,Switch Therapeutics ,Conditionally Activated ,Chief Technology Officer ,Si Ping Han ,Scientific Advisory ,Scientific Advisory Board ,Senior Vice President ,Medicinal Chemistry ,Regulus Therapeutics ,Stoke Therapeutics ,Vice President ,National Institutes ,Rna Interference ,Witchs Scientific Advisory Board ,Lorna Therapeutics ,Na ,Central Nervous System ,Biotechnology Company ,Herapeutics ,Phd ,